Phathom Pharmaceuticals Announces Completion of Patient Enrollment in Pivotal Phase 3 Erosive Esophagitis Trial
Topline results expected in second half of 2021 FLORHAM PARK, N.J., Nov. 30, 2020 (GLOBE…
Month: November 2020
Travere Therapeutics Announces Completion of Patient Enrollment in Pivotal Phase 3 DUPLEX Study of Sparsentan in Focal Segmental Glomerulosclerosis
Topline data from interim 36-week proteinuria endpoint on track for first quarter of 2021 SAN…
Galapagos reports positive topline results with GLPG1205 in IPF patients in PINTA Proof-of-Concept trial
Placebo-adjusted improvement in forced vital capacity (FVC) decline of 42mL across treatment groups at 26…
Intellia Therapeutics Announces Proposed Public Offering of Common Stock
CAMBRIDGE, Mass., Nov. 30, 2020 (GLOBE NEWSWIRE) — Intellia Therapeutics, Inc. (NASDAQ:NTLA), a leading genome…
ECMOHO Announces Third Quarter 2020 Unaudited Financial Results
SHANGHAI, China, Nov. 30, 2020 (GLOBE NEWSWIRE) — ECMOHO Limited (Nasdaq: MOHO) (“ECMOHO” or the…
Celldex Therapeutics to Present at 3rd Annual Evercore ISI HealthCONx Conference
HAMPTON, N.J., Nov. 30, 2020 (GLOBE NEWSWIRE) — Celldex Therapeutics, Inc. (NASDAQ:CLDX) announced today that…
IN8bio to Present at Upcoming December Investor Conferences
NEW YORK, Nov. 30, 2020 (GLOBE NEWSWIRE) — IN8bio, Inc., a clinical-stage biotechnology company focused…
Rubius Therapeutics to Participate in Evercore ISI 3rd Annual HealthCONx Conference
CAMBRIDGE, Mass., Nov. 30, 2020 (GLOBE NEWSWIRE) — Rubius Therapeutics, Inc. (Nasdaq:RUBY), a clinical-stage biopharmaceutical…
Chalice Farms Debuts New Flower Line, Bald Peak, Under New Director of Cultivation, Derek Rayhorn
PORTLAND, Ore., Nov. 30, 2020 (GLOBE NEWSWIRE) — Golden Leaf Holdings Ltd. (CSE:GLH) (OTCQB:GLDFF) (“Golden…
HIV-Like Virus Eliminated from the Genomes of Primates; Excision BioTherapeutics Advancing the Innovation to Clinical Development
Study published in Nature Communications marks a critical step toward the development of a possible…